Jun 08, 2020
Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device
Apr 30, 2020
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth
Apr 28, 2020
Surge in Demand for Anti-asthmatics and COPD Drugs due to Coronavirus, Reports TBRC
Mar 26, 2020
COVID-19: What Those with Lung Disease Should Know
Mar 24, 2020
Spirometers Market- Growth, Trends, and Forecast (2020 - 2025)
Feb 12, 2020
Bronchitis Treatment Market to Reach US$ 4.7 Bn by 2026, High Prevalence of Air Pollution Drives Growth: Transparency Market Research
Dec 18, 2019
Additional Patients Eligible for New COPD Treatment with Expansion of UnitedHealthcare® Coverage
Dec 12, 2019
New Pulmonary Rehabilitation Program is a Breath of Fresh Air for Those With Chronic Lung Disease
Dec 02, 2019
CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis
Nov 11, 2019
Asthma Sufferers Breathe a Sigh of Relief with Top Rated Product from TopConsumerReviews.com
Nov 07, 2019
Grifols introduces AlphaID(TM), a free cheek swab to screen for Alpha-1, the most common genetic form of COPD
Oct 14, 2019
Preventing COPD exacerbations during the coldest months may save lives, reduce hospitalizations and alleviate strain on health care resources
Oct 14, 2019
Identification of COPD, asthma and overlap syndrome can be teased out with spirometry following use of bronchodilator
Oct 14, 2019
Aclidinium is safe and reduces COPD flare-ups, regardless of recent exacerbations
Sep 26, 2019
New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
Sep 16, 2019
Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Sep 04, 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Jul 10, 2019
2019 Respiratory Care Devices Market Global Key Company Profiles, Demands and Growth by a CAGR of 10.06% During 2019-2024
May 18, 2019
Mylan Presents Equivalence and Device Usability Data on Wixela(TM) Inhub(TM) Compared to Advair Diskus® at American Thoracic Society International Conference
Apr 29, 2019
Visiongain Report Looks at Opportunities Within the $46bn Asthma & COPD Therapies Market